Anisometropia and myopia progression – patient management guidelines Meeting proceedings

Main Article Content

Joanna Przeździecka-Dołyk

Abstract

Anisometropia, or a diff erence in refraction between the eyes, can lead to aniseikonia – a difference in the size or shape of retinal images. Th e main symptoms include asthenopia and disturbances in stereopsis and spatial perception, including disturbances in movement patterns. Incorrectly applied correction can result in fusion disorders, headaches, diplopia, or amblyopia. Treatment requires appropriately selected spectacle or contact correction, taking into account the degree of aniseikonia, binocular balance, and visual rehabilitation. Pharmacological (e.g., atropine) and optical methods (DIMS glasses, MFSCL lenses, orthokeratology) are used to manage myopia progression. Th eir goal is to control myopic defocus at the periphery of the retina and slow down the growth of the eyeball, ideally with early implementation of therapy and lifestyle modifi cations (time outdoors, breaks from close-up work). Eff ective care requires cooperation between an ophthalmologist, optometrist, and in children, a pediatrician and educator to ensure proper visual development and functioning in the school environment.

Downloads

Download data is not yet available.

Article Details

How to Cite
1.
Przeździecka-Dołyk J. Anisometropia and myopia progression – patient management guidelines. Ophthatherapy [Internet]. 2025Aug.31 [cited 2026Feb.22];12(2):143-7. Available from: https://www.journalsmededu.pl/index.php/ophthatherapy/article/view/3403
Section
Conservative treatment

References

1. Qiao S, Chen J, Zhang J et al. Study on the impact of refractive anisometropia on strabismus, stereopsis, and amblyopia in children. Medicine (Baltimore). 2024; 103(44): e40205. http://doi.org/10.1097/MD.0000000000040205.
2. Levi DM, Knill DC, Bavelier D. Stereopsis and amblyopia: A mini-review. Vision Res. 2015; 114: 17-30. http://doi.org/10.1016/j.visres.2015.01.002.
3. Jiménez JR, Ponce A, Anera RG. Induced aniseikonia diminishes binocular contrast sensitivity and binocular summation. Optom Vis Sci. 2004; 81(7): 559-62. http://doi.org/10.1097/00006324-200407000-00019.
4. Nucci P, Lembo A, Schiavetti I et al. A comparison of myopia control in European children and adolescents with defocus incorporated multiple segments (DIMS) spectacles, atropine, and combined DIMS/atropine. PLoS One. 2023; 18(2): e0281816. http://doi.org/10.1371/journal.pone.0281816.
5. Gantes-Nuñez J, Jaskulski M, López-Gil N et al. Optical characterisation of two novel myopia control spectacle lenses. Ophthalmic Physiol Opt. 2023; 43(3): 388-401. http://doi.org/10.1111/opo.13098.
6. Buzzonetti L, Petroni S, Federici M et al. Effectiveness of Defocus Incorporated Multiple Segments in Slowing Myopia Progression in Pediatric Patients as a Function of Age: Three-Year Follow-Up. Diseases. 2024; 12(9): 222. http://doi.org/10.3390/diseases12090222.
7. Chamberlain P, Peixoto-de-Matos SC, Logan NS et al. A 3-year Randomized Clinical Trial of MiSight Lenses for Myopia Control. Optom Vis Sci. 2019; 96(8): 556-67. http://doi.org/10.1097/OPX.0000000000001410.
8. Xu S, Li Z, Zhao W et al. Effect of atropine, orthokeratology and combined treatments for myopia control: a 2-year stratified randomised clinical trial. Br J Ophthalmol. 2023; 107(12): 1812-7. http://doi.org/ 10.1136/bjo-2022-321272.
9. Lawrenson JG, Huntjens B, Virgili G et al. Interventions for myopia control in children: a living systematic review and network meta-analysis. Cochrane Database Syst Rev. 2025; 2(2): CD014758. http://doi.org/10.1002/14651858.CD014758.pub3.